APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loratadine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Loratadine Tablets Market Outlook and Growth Opportunities 2026

29 December 2025211 pages

Choose your research edition.

Industry ResearchLoratadine Tablets Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Loratadine Tablets Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Loratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loratadine Tablets Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Loratadine Tablets Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Loratadine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Loratadine Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Loratadine Tablets market include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Loratadine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Loratadine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Loratadine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loratadine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Loratadine Tablets Segment by Company

Anhui Guosen Pharmaceutical Co., Ltd.

Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.

Guangdong Hengcheng Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Heilongjiang Nuojie Pharmaceutical Co., Ltd.

Hubei Minkang Pharmaceutical Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd.

Hunan Zhongnan Pharmaceutical Co., Ltd.

Jilin Jinheng Pharmaceutical Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Shanxi Qianyuan Pharmaceutical Group Co., Ltd.

Shanxi Xinyu Pharmaceutical Co., Ltd.

Sichuan Deyuan Pharmaceutical Group Co., Ltd.

Sichuan Shenghe Pharmaceutical Co., Ltd.

Tonghua Great Wall Pharmaceutical Co., Ltd.

Yabao Pharmaceutical Group Co., Ltd.

Yunnan Longfa Pharmaceutical Co., Ltd.

Yunpeng Pharmaceutical Group Co., Ltd.

Zhejiang Ruixin Pharmaceutical Co., Ltd.

Zhejiang Asia Pacific Pharmaceutical Co., Ltd.

Loratadine Tablets Segment by Type

20 mg/Tablet

40 mg/Tablet

60 mg/Tablet

Loratadine Tablets Segment by Application

Hospital

Pharmacy

Online e-commerce

Other

Loratadine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Loratadine Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Loratadine Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Loratadine Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Loratadine Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Loratadine Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Loratadine Tablets industry.

Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Loratadine Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Loratadine Tablets Industry Trends Table 2. Loratadine Tablets Industry Drivers Table 3. Loratadine Tablets Industry Opportunities and Challenges Table 4. Loratadine Tablets Industry Restraints Table 5. Global Loratadine Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Loratadine Tablets Revenue Share by Company (2021-2026) Table 7. Global Loratadine Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Loratadine Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Loratadine Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Loratadine Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Loratadine Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Loratadine Tablets Company, Product Type & Application Table 13. Global Loratadine Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Loratadine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20 mg/Tablet Table 18. Significant Companies of 40 mg/Tablet Table 19. Significant Companies of 60 mg/Tablet Table 20. Global Loratadine Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Loratadine Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Loratadine Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Loratadine Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Loratadine Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Loratadine Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Loratadine Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Loratadine Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Loratadine Tablets Sales Value Share by Type (2021-2026) Table 29. Global Loratadine Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Online e-commerce Table 33. Significant Companies of Other Table 34. Global Loratadine Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Loratadine Tablets Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Loratadine Tablets Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Loratadine Tablets Sales Volume Share by Application (2021-2026) Table 38. Global Loratadine Tablets Sales Volume Share by Application (2027-2032) Table 39. Global Loratadine Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Loratadine Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Loratadine Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Loratadine Tablets Sales Value Share by Application (2021-2026) Table 43. Global Loratadine Tablets Sales Value Share by Application (2027-2032) Table 44. Global Loratadine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Loratadine Tablets Sales by Region (2021-2026) & (K Units) Table 46. Global Loratadine Tablets Sales Market Share by Region (2021-2026) Table 47. Global Loratadine Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Loratadine Tablets Sales Market Share by Region (2027-2032) Table 49. Global Loratadine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Loratadine Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Loratadine Tablets Sales Value Share by Region (2021-2026) Table 52. Global Loratadine Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Loratadine Tablets Sales Value Share by Region (2027-2032) Table 54. Global Loratadine Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Loratadine Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Loratadine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Loratadine Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Loratadine Tablets Sales by Country (2021-2026) & (K Units) Table 59. Global Loratadine Tablets Sales Market Share by Country (2021-2026) Table 60. Global Loratadine Tablets Sales by Country (2027-2032) & (K Units) Table 61. Global Loratadine Tablets Sales Market Share by Country (2027-2032) Table 62. Global Loratadine Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Loratadine Tablets Sales Value Market Share by Country (2021-2026) Table 64. Global Loratadine Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Loratadine Tablets Sales Value Market Share by Country (2027-2032) Table 66. Anhui Guosen Pharmaceutical Co., Ltd. Company Information Table 67. Anhui Guosen Pharmaceutical Co., Ltd. Business Overview Table 68. Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 70. Anhui Guosen Pharmaceutical Co., Ltd. Recent Development Table 71. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Company Information Table 72. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview Table 73. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 75. Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Development Table 76. Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information Table 77. Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview Table 78. Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 80. Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Development Table 81. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information Table 82. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview Table 83. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio Table 85. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Development Table 86. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 87. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 88. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 90. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 91. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information Table 92. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview Table 93. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 95. Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Development Table 96. Hubei Minkang Pharmaceutical Co., Ltd. Company Information Table 97. Hubei Minkang Pharmaceutical Co., Ltd. Business Overview Table 98. Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 100. Hubei Minkang Pharmaceutical Co., Ltd. Recent Development Table 101. Hunan Erkang Pharmaceutical Co., Ltd. Company Information Table 102. Hunan Erkang Pharmaceutical Co., Ltd. Business Overview Table 103. Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 105. Hunan Erkang Pharmaceutical Co., Ltd. Recent Development Table 106. Hunan Zhongnan Pharmaceutical Co., Ltd. Company Information Table 107. Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview Table 108. Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 110. Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Development Table 111. Jilin Jinheng Pharmaceutical Co., Ltd. Company Information Table 112. Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview Table 113. Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 115. Jilin Jinheng Pharmaceutical Co., Ltd. Recent Development Table 116. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 117. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 118. Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 120. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Development Table 121. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information Table 122. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview Table 123. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio Table 125. Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Development Table 126. Shanxi Xinyu Pharmaceutical Co., Ltd. Company Information Table 127. Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview Table 128. Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 130. Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Development Table 131. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information Table 132. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview Table 133. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio Table 135. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Development Table 136. Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information Table 137. Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview Table 138. Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 140. Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Development Table 141. Tonghua Great Wall Pharmaceutical Co., Ltd. Company Information Table 142. Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview Table 143. Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 145. Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Development Table 146. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 147. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 148. Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio Table 150. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 151. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information Table 152. Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview Table 153. Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 155. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Development Table 156. Yunpeng Pharmaceutical Group Co., Ltd. Company Information Table 157. Yunpeng Pharmaceutical Group Co., Ltd. Business Overview Table 158. Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio Table 160. Yunpeng Pharmaceutical Group Co., Ltd. Recent Development Table 161. Zhejiang Ruixin Pharmaceutical Co., Ltd. Company Information Table 162. Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview Table 163. Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 165. Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Development Table 166. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information Table 167. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview Table 168. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio Table 170. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Loratadine Tablets Distributors List Table 174. Loratadine Tablets Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Loratadine Tablets Product Image Figure 2. Global Loratadine Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Loratadine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Loratadine Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Loratadine Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20 mg/Tablet Image Figure 10. 40 mg/Tablet Image Figure 11. 60 mg/Tablet Image Figure 12. Global Loratadine Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Loratadine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Loratadine Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Loratadine Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Loratadine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Loratadine Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Online e-commerce Image Figure 21. Other Image Figure 22. Global Loratadine Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Loratadine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Loratadine Tablets Sales Volume Share by Application (2021-2032) Figure 25. Global Loratadine Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Loratadine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Loratadine Tablets Sales Value Share by Application (2021-2032) Figure 28. Global Loratadine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Loratadine Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Loratadine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Loratadine Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. North America Loratadine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Loratadine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Loratadine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. South America Loratadine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Loratadine Tablets Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Loratadine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Loratadine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Loratadine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Loratadine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Loratadine Tablets Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Loratadine Tablets Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/Tablet
  • 40 mg/Tablet
  • 60 mg/Tablet
Applications
  • Hospital
  • Pharmacy
  • Online e-commerce
  • Other
Companies covered
  • Anhui Guosen Pharmaceutical Co., Ltd.
  • Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
  • Guangdong Hengcheng Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Heilongjiang Nuojie Pharmaceutical Co., Ltd.
  • Hubei Minkang Pharmaceutical Co., Ltd.
  • Hunan Erkang Pharmaceutical Co., Ltd.
  • Hunan Zhongnan Pharmaceutical Co., Ltd.
  • Jilin Jinheng Pharmaceutical Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
  • Shanxi Xinyu Pharmaceutical Co., Ltd.
  • Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  • Sichuan Shenghe Pharmaceutical Co., Ltd.
  • Tonghua Great Wall Pharmaceutical Co., Ltd.
  • Yabao Pharmaceutical Group Co., Ltd.
  • Yunnan Longfa Pharmaceutical Co., Ltd.
  • Yunpeng Pharmaceutical Group Co., Ltd.
  • Zhejiang Ruixin Pharmaceutical Co., Ltd.
  • Zhejiang Asia Pacific Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loratadine Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Loratadine Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Loratadine Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Loratadine Tablets Market Dynamics
  1. 2.1 Loratadine Tablets Industry Trends
  2. 2.2 Loratadine Tablets Industry Drivers
  3. 2.3 Loratadine Tablets Industry Opportunities and Challenges
  4. 2.4 Loratadine Tablets Industry Restraints
3 Loratadine Tablets Market by Company
  1. 3.1 Global Loratadine Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Loratadine Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Loratadine Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Loratadine Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Loratadine Tablets Company Ranking (2024-2026)
  6. 3.6 Global Loratadine Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Loratadine Tablets Company Product Type and Application
  8. 3.8 Global Loratadine Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Loratadine Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Loratadine Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Loratadine Tablets Market by Type
  1. 4.1 Loratadine Tablets Type Introduction
  2. 4.1.1 20 mg/Tablet
  3. 4.1.2 40 mg/Tablet
  4. 4.1.3 60 mg/Tablet
  5. 4.2 Global Loratadine Tablets Sales Volume by Type
  6. 4.2.1 Global Loratadine Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Loratadine Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Loratadine Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Loratadine Tablets Sales Value by Type
  10. 4.3.1 Global Loratadine Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Loratadine Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Loratadine Tablets Sales Value Share by Type (2021-2032)
5 Loratadine Tablets Market by Application
  1. 5.1 Loratadine Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Online e-commerce
  5. 5.1.4 Other
  6. 5.2 Global Loratadine Tablets Sales Volume by Application
  7. 5.2.1 Global Loratadine Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Loratadine Tablets Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Loratadine Tablets Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Loratadine Tablets Sales Value by Application
  11. 5.3.1 Global Loratadine Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Loratadine Tablets Sales Value by Application (2021-2032)
  13. 5.3.3 Global Loratadine Tablets Sales Value Share by Application (2021-2032)
6 Loratadine Tablets Regional Sales and Value Analysis
  1. 6.1 Global Loratadine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Loratadine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Loratadine Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Loratadine Tablets Sales by Region (2027-2032)
  5. 6.3 Global Loratadine Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Loratadine Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Loratadine Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Loratadine Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Loratadine Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Loratadine Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Loratadine Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Loratadine Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Loratadine Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Loratadine Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Loratadine Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Loratadine Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Loratadine Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Loratadine Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Loratadine Tablets Sales Value Share by Country, 2025 VS 2032
7 Loratadine Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Loratadine Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Loratadine Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Loratadine Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Loratadine Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Loratadine Tablets Sales by Country (2027-2032)
  6. 7.4 Global Loratadine Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Loratadine Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Loratadine Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Loratadine Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Loratadine Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Loratadine Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Loratadine Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Loratadine Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Loratadine Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Loratadine Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Loratadine Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Loratadine Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Loratadine Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Loratadine Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Loratadine Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Loratadine Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Loratadine Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Loratadine Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Loratadine Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Loratadine Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Loratadine Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Loratadine Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Loratadine Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Loratadine Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Loratadine Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Loratadine Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Loratadine Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Loratadine Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Loratadine Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Loratadine Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Loratadine Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Loratadine Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Loratadine Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Guosen Pharmaceutical Co., Ltd.
  2. 8.1.1 Anhui Guosen Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  6. 8.1.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
  8. 8.2.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  12. 8.2.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Guangdong Hengcheng Pharmaceutical Co., Ltd.
  14. 8.3.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  18. 8.3.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
  24. 8.4.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  26. 8.5.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  30. 8.5.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
  32. 8.6.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  36. 8.6.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hubei Minkang Pharmaceutical Co., Ltd.
  38. 8.7.1 Hubei Minkang Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  42. 8.7.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Hunan Erkang Pharmaceutical Co., Ltd.
  44. 8.8.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  48. 8.8.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Hunan Zhongnan Pharmaceutical Co., Ltd.
  50. 8.9.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  54. 8.9.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin Jinheng Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin Jinheng Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  60. 8.10.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Sancai Shiqi Pharmaceutical Co., Ltd.
  62. 8.11.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  66. 8.11.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
  68. 8.12.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information
  69. 8.12.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
  70. 8.12.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
  72. 8.12.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
  73. 8.13 Shanxi Xinyu Pharmaceutical Co., Ltd.
  74. 8.13.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  78. 8.13.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  80. 8.14.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
  81. 8.14.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
  82. 8.14.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
  84. 8.14.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
  85. 8.15 Sichuan Shenghe Pharmaceutical Co., Ltd.
  86. 8.15.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  90. 8.15.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Tonghua Great Wall Pharmaceutical Co., Ltd.
  92. 8.16.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  96. 8.16.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Yabao Pharmaceutical Group Co., Ltd.
  98. 8.17.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  99. 8.17.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  100. 8.17.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
  102. 8.17.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  103. 8.18 Yunnan Longfa Pharmaceutical Co., Ltd.
  104. 8.18.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  108. 8.18.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Yunpeng Pharmaceutical Group Co., Ltd.
  110. 8.19.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
  111. 8.19.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
  112. 8.19.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
  114. 8.19.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
  115. 8.20 Zhejiang Ruixin Pharmaceutical Co., Ltd.
  116. 8.20.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  120. 8.20.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
  122. 8.21.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
  126. 8.21.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Loratadine Tablets Value Chain Analysis
  2. 9.1.1 Loratadine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Loratadine Tablets Sales Mode & Process
  6. 9.2 Loratadine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Loratadine Tablets Distributors
  9. 9.2.3 Loratadine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst